These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. High prevalence of varicella-zoster virus reactivation in herpes simplex virus-seronegative patients with acute peripheral facial palsy. Furuta Y; Ohtani F; Kawabata H; Fukuda S; Bergström T Clin Infect Dis; 2000 Mar; 30(3):529-33. PubMed ID: 10722439 [TBL] [Abstract][Full Text] [Related]
23. [Reactivation of herpes zoster infection by varicella-zoster virus]. Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396 [TBL] [Abstract][Full Text] [Related]
24. [Complications in two children with acute lymphatic leukemia caused by vaccination against varicella zoster virus]. Christensen CL; Poulsen A; Böttiger B; Kirk M; Andersen HK; Schmiegelow K Ugeskr Laeger; 1999 Feb; 161(6):794-6. PubMed ID: 10068350 [TBL] [Abstract][Full Text] [Related]
25. [Pathogenesis of herpes zoster]. Smirnov IuK; Shishov AS Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):3-7. PubMed ID: 2543167 [TBL] [Abstract][Full Text] [Related]
26. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation. Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065 [TBL] [Abstract][Full Text] [Related]
27. [Herpesvirus latency]. Langeland N Tidsskr Nor Laegeforen; 1990 Sep; 110(21):2785-7. PubMed ID: 2171156 [TBL] [Abstract][Full Text] [Related]
29. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child. Levin MJ; Dahl KM; Weinberg A; Giller R; Patel A; Krause PR J Infect Dis; 2003 Oct; 188(7):954-9. PubMed ID: 14513413 [TBL] [Abstract][Full Text] [Related]
30. Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. Mancuso R; Delbue S; Borghi E; Pagani E; Calvo MG; Caputo D; Granieri E; Ferrante P J Med Virol; 2007 Feb; 79(2):192-9. PubMed ID: 17177306 [TBL] [Abstract][Full Text] [Related]
31. Immune evasion as a pathogenic mechanism of varicella zoster virus. Abendroth A; Arvin AM Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797 [TBL] [Abstract][Full Text] [Related]
32. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine. Levin MJ; DeBiasi RL; Bostik V; Schmid DS J Infect Dis; 2008 Nov; 198(10):1444-7. PubMed ID: 18826373 [TBL] [Abstract][Full Text] [Related]
34. Molecular studies of Varicella zoster virus. Quinlivan M; Breuer J Rev Med Virol; 2006; 16(4):225-50. PubMed ID: 16791838 [TBL] [Abstract][Full Text] [Related]
35. Herpes zoster in the distribution of the trigeminal nerve after nonablative fractional photothermolysis of the face: report of 3 cases. Firoz BF; Katz TM; Goldberg LH; Geronemus RG; Polder KD; Friedman PM Dermatol Surg; 2011 Feb; 37(2):249-52. PubMed ID: 21281388 [No Abstract] [Full Text] [Related]
36. Disseminated herpes zoster in immunocompetent patients not due to varicella-zoster virus gene mutation. Sun ZH; Guo YY; Li M; Yao ZR Chin Med J (Engl); 2013 Aug; 126(16):3193. PubMed ID: 23981640 [No Abstract] [Full Text] [Related]
37. Reactivation of varicella-zoster virus during acute malaria. Brown AE; Pipithkul J; Webster HK Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):139-40. PubMed ID: 1658946 [No Abstract] [Full Text] [Related]
39. Commentary: Herpes zoster in the distribution of the trigeminal nerve after nonablative fractional photothermolysis of the face. Nelson AA; Lask GP Dermatol Surg; 2011 Feb; 37(2):253-5. PubMed ID: 21324033 [No Abstract] [Full Text] [Related]